BRANDON REID: Open Payments
NPI 1366088189 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 31 payments from 7 companies in 2025. Trend: 2023 $385 · 2024 $0 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 17 | $250 |
| Janssen Pharmaceuticals, Inc | 6 | $105 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Alkermes, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: General - DBS, INVEGA SUSTENNA, ARISTADA, UZEDY, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE, VRAYLAR, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
